You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 202151 - 202160 of 207726 results
  1. VACCESS: INTERACTIVE IMMUNIZATION INFORMATION SYSTEM

    SBC: Leap Of Faith Technologies Inc            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  2. VACCINATION AGAINST HOOKWORM WITH RECOMBINANT ANTIGENS

    SBC: L2 DIAGNOSTICS LLC            Topic: N/A

    Not Available Chemical weapons are highly lethal, inexpensive weapons of mass destruction. Present methods for detection of exposure to sulfur mustard are expensive and time-consuming. Accordingly, there is an urgent need for the development of rapid, simple, and reliable detection methods capable of monitoring of toxic compounds for clinical treatment and diagnosis after exposure to sulfur mus ...

    SBIR Phase I 1999 Department of Health and Human Services
  3. Vaccination Against Ixodes scapularis Tick Bites

    SBC: L2 DIAGNOSTICS LLC            Topic: N/A

    Lyme disease is a multi-systemic infection and is caused by the pathogen Borrelia burgdorferi. The blacklegged tick, Ixodes scapularis, is the common vector for B. burgdorferi. The purpose of this project is to develop an anti-I. scapularis vaccine to block tick attachment and tick-mediated disease transmission. . Rabbits or guinea pigs infested with I. scapularis acquire antibody- mediated resist ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  4. VACCINATION AGAINST IXODES SCAPULARIS TICK BITES

    SBC: L2 DIAGNOSTICS LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Lyme disease is a multi-systemic infection caused by the pathogen Borrelia burgdorjeri. The black-legged tick, Ixodes scapularis, is the common vector for B. burgdorferi. This tick also transmits the agents of human granulocytic ehrlichiosis and babesiosis. The purpose of this project is to develop an anti-I. scapiilaris vaccine to block tick attachment and tic ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  5. VACCINATION AGAINST IXODES SCAPULARIS TICK BITES

    SBC: L2 DIAGNOSTICS LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Lyme disease is a multi-systemic infection caused by the pathogen Borrelia burgdorjeri. The black-legged tick, Ixodes scapularis, is the common vector for B. burgdorferi. This tick also transmits the agents of human granulocytic ehrlichiosis and babesiosis. The purpose of this project is to develop an anti-I. scapiilaris vaccine to block tick attachment and tic ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  6. Vaccination Against West Nile Virus

    SBC: L2 DIAGNOSTICS LLC            Topic: N/A

    A commercially viable vaccine for the prevention of West Nile virus infection is the overall objective of this project. West Nile virus was isolated for the first time in the Western hemisphere in 1999, when seven New York patients died as a result of a West Nile virus outbreak. The virus is still present in North America. A vaccine will be an important complement to other public health measures, ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  7. Vaccination Against West Nile Virus

    SBC: L2 DIAGNOSTICS LLC            Topic: N/A

    DESCRIPTION (provided by applicant): A commercially viable recombinant subunit vaccine to prevent West Nile virus infection is the overall objective of this project. West Nile virus was isolated for the first time in North America in 1999. In less than three years, the geographical distribution of the virus expanded dramatically in the United States. A vaccine will be an important complement to ...

    SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health
  8. Vaccination Against West Nile Virus

    SBC: L2 DIAGNOSTICS LLC            Topic: N/A

    DESCRIPTION (provided by applicant): A commercially viable recombinant subunit vaccine to prevent West Nile virus infection is the overall objective of this project. West Nile virus was isolated for the first time in North America in 1999. In less than three years, the geographical distribution of the virus expanded dramatically in the United States. A vaccine will be an important complement to ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  9. Vaccination against Zika virus infection using mosquito NeSt1 protein

    SBC: L2 DIAGNOSTICS LLC            Topic: NIAID

    Arthropod-borne viruses (arboviruses) present a substantial threat to human and animal health worldwide. They are transmitted by hematophagous arthropods, in which mosquitoes are one of the main transmitters. The mosquito specie, Aedes aegypti, is the primary mosquito vector of several widely spread arboviruses as zika, dengue or West Nile viruses. Mosquitoes transmit these pathogens by inoculatin ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  10. VACCINATION BY TOPICAL APPLICATION OF CONDENSED DNA

    SBC: COPERNICUS THERAPEUTICS, INC.            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesCenters for Disease Control and Prevention
US Flag An Official Website of the United States Government